结肠直肠神经内分泌新生瘤的发病率趋势和相对存活率:使用德国癌症注册数据的基于人口的研究

Lennart Möller1,2, Andras Szentkirályi1, Christine Eisfeld1

  • 1Cancer Registry of North Rhine Westphalia, Bochum, Germany.

PubMed
概括

结直肠神经内分泌瘤 (NENs) 的发生率,包括神经内分泌瘤 (NETs) 和混合神经内分泌与非神经内分泌瘤 (MiNENs),正在上升,特别是在年轻患者中. 对NET的生存率高于神经内分泌癌 (NEC),直肠NET显示出最好的预后.

相关概念视频

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
321
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
122